Results 171 to 180 of about 100,759 (296)

Nose-to-Brain Delivery of Chlorella vulgaris Extracellular Vesicles for Antidepressant Effects. [PDF]

J Extracell Vesicles
Jin K, Wang R, Chen B, Zhong D, Cheng S, Tong A, Qi Y, Lu J, Zhou M.   +8 more
europepmc   +1 more source

Ménière's Disease: A Tri‐Decade Scoping Review of Treatment Trends and Evidence Quality

The Laryngoscope, EarlyView.
This tri‐decade scoping review of Ménière's disease literature reveals a significant increase in high‐level evidence and a clinical pivot toward hearing‐preserving interventions, such as intratympanic steroids and cochlear implants. However, a significant quality paradox has emerged, where adherence to standardized AAO‐HNS reporting and diagnostic ...
Ofir Zavdy, Teeraya Piyajarawong, Seamus Boyle, Ross O'Shea, John Rutka   +4 more
wiley   +1 more source

Design of Experiments (DoE)-Optimized Polymeric Oxytocin Nanoparticles for Enhanced Nose-to-Brain Delivery. [PDF]

Small
Ahmad N, Han S, Utami R, Baker R, Helal D, Li Z, Tricklebank M, Paloyelis Y, Wang J, Petrinovic MM, Bansal S, Al-Jamal KT.   +11 more
europepmc   +1 more source

Thermoresponsive Gel-loaded Oxcarbazepine Nanosystems for Nose- To-Brain Delivery: Enhanced Antiepileptic Activity in Rats. [PDF]

Pharm Res, 2023
Abou-Taleb BA, El-Ganainy SO.
europepmc   +1 more source

AI‐powered nursing handoffs: Introducing and evaluating the patient report template

Learning Health Systems, EarlyView.
Abstract Purpose To understand (1) if nurses view the individual components of the Patient Report Template as useful in their day‐to‐day workflow, and (2) understand the perceptions of nurses related to artificial intelligence use in their day‐to‐day work.
Gabriel Vald, Yusuf Sermet, Nai‐Ching Chi, Ibrahim Demir   +3 more
wiley   +1 more source

Focused ultrasound-enhanced nose-to-brain delivery of a therapeutic antibody in a large-animal model. [PDF]

Theranostics
Fadera S, Boas CAWV, Yue Y, Gu Z, Yuan J, De D, Rogers BE, Nazeri A, Chen H.   +8 more
europepmc   +1 more source

Development of Atomoxetine-Loaded NLC In Situ Gel for Nose-to-Brain Delivery: Optimization, In Vitro, and Preclinical Evaluation. [PDF]

Pharmaceutics, 2023
Mohanty D, Alsaidan OA, Zafar A, Dodle T, Gupta JK, Yasir M, Mohanty A, Khalid M.   +7 more
europepmc   +1 more source

Optimization of Bromocriptine-Mesylate-Loaded Polycaprolactone Nanoparticles Coated with Chitosan for Nose-to-Brain Delivery: In Vitro and In Vivo Studies. [PDF]

Polymers (Basel), 2023
Badran MM, Alanazi AE, Ibrahim MA, Alshora DH, Taha E, H Alomrani A.   +5 more
europepmc   +1 more source

Exocrine Gland Dysfunction in Parkinson's Disease: Pathophysiology, Clinical Manifestations, and Therapeutic Perspectives—A Narrative Review

Movement Disorders Clinical Practice, EarlyView.
Abstract Background Non‐motor symptoms, especially autonomic dysfunction, are major contributors to disability and decreased quality of life in Parkinson's disease (PD). Despite being common and having a wide range of clinical facets, exocrine gland dysfunction is still not well recognized and managed.
Renato P. Munhoz, Marina Farah, Laura Silveira‐Moriyama   +2 more
wiley   +1 more source

Polymeric Nanocarrier-Based Drug Formulations for Enhancing Nose-to-Brain Delivery. [PDF]

Pharmaceutics
Naki T, Peter S, Alven S.
europepmc   +1 more source